Wall Street analyst estimates for Evercore Inc. (EVR): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
Evercore Inc. functions as an autonomous investment banking advisory firm, maintaining a substantial international presence with operations spanning the United States, Europe, and Latin America. The company is structured into two core business units: Investment Banking and Investment Management.
Consensus price target
$439.60 (+45 % vs price $303.26)
between $315.00 and $870.00 · 8 targets published in the last quarter
Closing price, Nov 2
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2026E | $4.9B | $4.8B – $5.0B | $19.78 | 6 |
| 2027E | $5.3B | $4.9B – $5.8B | $21.32 | 6 |
Figures in USD · consensus as of November 2, 2026
Analyst Consensus
| Strong Buy | 0 |
| Buy | 11 |
| Hold | 10 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 22 |
| Avg rating (−2 sell to +2 buy) | 0.46 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2027-02-03 | $5.21 | ||
| 2026-10-28 | $4.28 | $2.52 | +69.8% |
| 2026-07-29 | $2.91 | $3.03 | -4.0% |
| 2026-04-29 | $7.53 | $5.43 | +38.7% |
| 2026-02-04 | $5.13 | $3.83 | +33.9% |
| 2025-10-29 | $3.48 | $3.25 | +7.1% |
| 2025-07-30 | $2.42 | $1.78 | +36.0% |
| 2025-04-30 | $3.49 | $1.54 | +126.6% |
Valuation Ratios
| P/E Ratio | 16.65 |
| Price / Book | 0.00 |
| Dividend Yield | 1.14% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.46B | $1.72B | $2.08B | $2.03B | $2.29B | $3.31B | $2.78B | $2.44B | $3.00B | $3.88B |
| Cost of Revenue | $16.7M | $20.0M | $17.8M | $20.1M | $21.4M | $17.6M | $16.9M | $16.7M | $16.8M | $24.3M |
| Gross Profit | $1.44B | $1.70B | $2.06B | $2.01B | $2.26B | $3.29B | $2.76B | $2.43B | $2.98B | $3.86B |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $900.6M | $962.5M | $1.20B | $1.20B | $1.37B | $1.85B | $1.70B | $1.66B | $1.97B | $2.50B |
| Operating Expenses | $1.17B | $1.27B | $1.51B | $1.56B | $1.72B | $2.17B | $2.06B | $2.06B | $2.45B | $3.06B |
| Operating Income | $267.8M | $437.6M | $551.4M | $448.7M | $540.8M | $1.12B | $704.0M | $365.8M | $533.1M | $793.8M |
| EBITDA | $293.0M | $463.7M | $580.7M | $484.4M | $570.8M | $1.15B | $732.7M | $368.2M | $532.8M | $804.4M |
| Interest Expense | $16.7M | $20.0M | $17.8M | $20.1M | $21.4M | $17.6M | $16.9M | $16.7M | $16.8M | $24.3M |
| Pre-tax Income | $267.8M | $437.6M | $551.4M | $448.7M | $540.8M | $1.12B | $704.0M | $365.8M | $533.1M | $793.8M |
| Income Tax | $119.3M | $258.4M | $108.5M | $95.0M | $128.2M | $248.0M | $172.6M | $80.6M | $115.4M | $153.1M |
| Net Income | $107.5M | $125.5M | $377.2M | $297.4M | $350.6M | $740.1M | $476.5M | $255.5M | $378.3M | $591.9M |
| EPS | $2.74 | $3.16 | $8.33 | $7.44 | $8.64 | $18.48 | $12.15 | $6.71 | $9.86 | $15.29 |
| EPS (Diluted) | $2.43 | $2.80 | $8.33 | $6.89 | $8.22 | $17.08 | $11.61 | $6.37 | $9.08 | $14.05 |
| Shares Outstanding (Diluted) | 44.2 M | 44.8 M | 45.3 M | 43.2 M | 42.6 M | 43.3 M | 41.0 M | 40.1 M | 41.6 M | 44.4 M |
Price
| Price | $303.26 (closing price, November 2, 2026) |
| Market Cap | $11.7B |
| Exchange | NYSE |
| Country | US |
Related companies: NMR · SF · HLI · JEF · MC · LAZ · PJT · PIPR
Explore sector: Financial Services · Financial - Capital Markets
More sections of EVR: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks